Application 020168
- Type
- BLA
- Sponsor
- GENENTECH
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 020168 | Nutropin | somatropin | 351(a) | Disc | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NUTROPIN | SOMATROPIN | INJECTABLE;INJECTION | 5MG/VIAL | No | No |
| 002 | NUTROPIN | SOMATROPIN | INJECTABLE;INJECTION | 10MG/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HUMATROPE | SOMATROPIN | Eli Lilly and Company | a774e1ae-3997-49ee-8b0e-99a2b315d409 | 2026-08-20 | Warnings, Adverse reactions | SOMATROPIN |
| GENOTROPIN | SOMATROPIN | Pfizer Laboratories Div Pfizer Inc | ffebf88b-d257-4542-9808-74d9b7167765 | 2026-08-04 | Warnings, Adverse reactions | SOMATROPIN |
| ZOMACTON | SOMATROPIN | Ferring Pharmaceuticals Inc. | 85ba081b-bee0-4a9a-aa0f-ae5b5e9a0886 | 2026-04-20 | Warnings, Adverse reactions | SOMATROPIN |
| Omnitrope | SOMATROPIN | Sandoz Inc | 58d84ffa-4056-4e36-ad67-7bd4aef444a5 | 2025-07-10 | Warnings, Adverse reactions | SOMATROPIN |
| Norditropin | SOMATROPIN | Novo Nordisk | 1058e17c-9261-459c-a3e6-fae38d196c14 | 2025-07-07 | Warnings, Adverse reactions | SOMATROPIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.